Literature DB >> 7919616

Survival of patients with multiple system atrophy.

Y Saito1, Y Matsuoka, A Takahashi, Y Ohno.   

Abstract

We investigated the survival of patients with multiple system atrophy (MSA) in a follow-up study of 59 patients admitted to Nagoya University Hospital between 1976 and 1991. They consisted of 24 patients with olivopontocerebellar atrophy (OPCA), 25 with Shy-Drager syndrome (SDS) and 10 with striatonigral degeneration (SND). The mean age at onset was 54 years, the 3-year survival rate from onset was 90%, and the 6-year survival rate was 54%. Comparison of survival curve by clinical type revealed poorer survival in SDS and SND than in OPCA cases. Although in OPCA, SND and SDS the pathological alterations of the central nervous system are known to be very similar, characterized as MSA, the present study suggests that the earlier and the more severe the involvement of the autonomic nervous system, and to a lesser extent the striatonigral system, the poorer the prognosis may be.

Entities:  

Mesh:

Year:  1994        PMID: 7919616     DOI: 10.2169/internalmedicine.33.321

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  16 in total

Review 1.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 2.  Prevalence of orthostatic hypotension.

Authors:  Phillip A Low
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

Review 3.  Preventing and treating orthostatic hypotension: As easy as A, B, C.

Authors:  Juan J Figueroa; Jeffrey R Basford; Phillip A Low
Journal:  Cleve Clin J Med       Date:  2010-05       Impact factor: 2.321

4.  The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.

Authors:  David J Lin; Katherine L Hermann; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

5.  Progression of parkinsonism in multiple system atrophy.

Authors:  Klaus Seppi; Farid Yekhlef; Anja Diem; Elisabeth Luginger Wolf; Joerg Mueller; François Tison; Niall P Quinn; Werner Poewe; Gregor K Wenning
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  Multiple system atrophy: prognostic indicators of survival.

Authors:  Juan J Figueroa; Wolfgang Singer; Ajay Parsaik; Eduardo E Benarroch; J Eric Ahlskog; Robert D Fealey; Joseph E Parisi; Paola Sandroni; Jay Mandrekar; Valeria Iodice; Phillip A Low; James H Bower
Journal:  Mov Disord       Date:  2014-06-07       Impact factor: 10.338

7.  Assessment of cardiovascular autonomic dysfunction in multiple system atrophy.

Authors:  S Kitae; Y Murata; N Tachiki; M Okazaki; T Harada; S Nakamura
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

8.  QT interval and dispersion in primary autonomic failure.

Authors:  S S Lo; C J Mathias; M S Sutton
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

9.  Clinical features and autonomic testing predict survival in multiple system atrophy.

Authors:  Elizabeth A Coon; David M Sletten; Mariana D Suarez; Jay N Mandrekar; J Eric Ahlskog; James H Bower; Joseph Y Matsumoto; Michael H Silber; Eduardo E Benarroch; Robert D Fealey; Paola Sandroni; Phillip A Low; Wolfgang Singer
Journal:  Brain       Date:  2015-09-13       Impact factor: 13.501

10.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.

Authors:  Axel Lipp; Paola Sandroni; J Eric Ahlskog; Robert D Fealey; Kurt Kimpinski; Valeria Iodice; Tonette L Gehrking; Stephen D Weigand; David M Sletten; Jade A Gehrking; Kim K Nickander; Wolfgang Singer; Demetrius M Maraganore; Sid Gilman; Gregor K Wenning; Clifford W Shults; Phillip A Low
Journal:  Arch Neurol       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.